Global gene expression profiling in three tumor cell lines subjected to experimental cycling and chronic hypoxia

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Olbryt, Magdalena ^a   Habryka, Anna ^a   Student, Sebastian ^b   Jarza̧b, Michał ^a   Tyszkiewicz, Tomasz ^a   Lisowska, Katarzyna Marta ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b SILESIAN UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANOXIA; GENE EXPRESSION PROFILING; GENETICS; HUMAN; NEOPLASM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; VALIDATION STUDY;

ANOXIA; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; HUMANS; NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84905992256     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105104     Document Type: Article

References (60)

1. Vaupel P, Harrison L (2004) Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response. The Oncologist 9: 4-9. (Pubitemid 39658340)
2. Brown JM (1979) Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation. Br J Radiol 52: 650-656.
3. Chaplin DJ, Olive PL, Durand RE (1987) Intermittent blood flow in a murine tumor: radiobiological effects. Cancer Res 47: 597-601. (Pubitemid 17009632)
4. Brurberg KG, Skogmo HK, Graff BA, Olsen DR, Rofstad EK (2005) Fluctuations in pO2 in poorly and well-oxygenated spontaneous canine tumors before and during fractionated radiation therapy. Radiother Oncol 77: 220-226. (Pubitemid 41682391)
5. Lanzen J, Braun RD, Klitzman B, Brizel D, Secomb TW, et al. (2006) Dewhirst MW: Direct demonstration of instabilities in oxygen concentrations within the extravascular compartment of an experimental tumor. Cancer Res 66: 2219-2223.
6. Cárdenas-Navia LI, Mace D, Richardson RA, Wilson DF, Shan S, et al. (2008) The pervasive presence of fluctuating oxygenation in tumors. Cancer Res 68: 5812-5819.
7. Kimura H, Braun RD, Ong ET, Hsu R, Secomb TW, et al. (1996) Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. Cancer Res 56: 5522-5528. (Pubitemid 27011389)
8. Pigott KH, Hill SA, Chaplin DJ, Saunders MI (1996) Microregional fluctuations in perfusion within human tumours detected using laser Doppler flowmetry. Radiother Oncol 40: 45-50. (Pubitemid 26246264)
9. Matsumoto S, Yasui H, Mitchell JB, Krishna MC (2010) Imaging cycling tumor hypoxia. Cancer Res 70: 10019-10023.
10. Rofstad EK, Galappathi K, Mathiesen B, Ruud EB (2007) Fluctuating and diffusion-limited hypoxia in hypoxia-induced metastasis. Clin Cancer Res 3: 1971-1978. (Pubitemid 46649862)
11. Cairns RA, Kalliomaki T, Hill RP (2001) Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors. Cancer Res 61: 8903-8908. (Pubitemid 34013907)
12. Cairns RA, Hill RP (2004) Acute hypoxia enhances spontaneous lymph node metastasis in an orthotopic murine model of human cervical carcinoma. Cancer Res 64: 2054-2061. (Pubitemid 38339453)
13. Rofstad EK, Gaustad JV, Egeland TA, Mathiesen B, Galappathi K (2010) Tumors exposed to acute cyclic hypoxic stress show enhanced angiogenesis, perfusion and metastatic dissemination. Int J Cancer 27: 1535-1546.
14. Hsieh CH, Shyu WC, Chiang CY, Kuo JW, Shen WC, et al. (2011) NADPH oxidase subunit 4-mediated reactive oxygen species contribute to cycling hypoxia-promoted tumor progression in glioblastoma multiforme. PLoS One 6: e23945.
15. Martinive P, Defresne F, Bouzin C, Saliez J, Lair F, et al. (2006) Preconditioning of the tumor vasculature and tumor cells by intermittent hypoxia: implications for anticancer therapies. Cancer Res 66: 11736-11744. (Pubitemid 46094185)
16. Weinmann M, Jendrossek V, Güner D, Goecke B, Belka C (2005) Cyclic exposure to hypoxia and reoxygenation selects for tumor cells with defects in mitochondrial apoptotic pathways. FASEB J 18: 1906-1908. (Pubitemid 39602279)
17. Reynolds TY, Rockwell S, Glazer PM (1996) Genetic instability induced by the tumor microenvironment. Cancer Res 56: 5754-5757. (Pubitemid 26422184)
18. Durand RE (2001) Intermittent blood flow in solid tumours-an underappreciated source of 'drug resistance'. Cancer Metastasis Rev 20: 57-61.
19. Louie E, Nik S, Chen JS, Schmidt M, Song B, et al. (2010) Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation. Breast Cancer Res 12: R94.
20. Dietz A, Vanselow B, Rudat V, Conradt C, Weidauer H (2003) Prognostic impact of reoxygenation in advanced cancer of the head and neck during the initial course of chemoradiation or radiotherapy alone. Head Neck 25: 50-58. (Pubitemid 36005331)
21. Wright GW, Simon RM (2003) A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics 18: 2448-2455. (Pubitemid 38016644)
22. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. J Roy Statist Soc B 85: 289-300.
23. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102: 15545-15550. (Pubitemid 41528093)
24. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
25. Dewhirst MW (2007) Intermittent hypoxia furthers the rationale for hypoxia-inducible factor-1 targeting. Cancer Res 67: 854-5.
26. Kim YJ, Ahn JY, Liang P, Ip C, Zhang Y, et al. (2007) Human prx1 gene is a target of Nrf2 and is up-regulated by hypoxia/reoxygenation: implication to tumor biology. Cancer Res 67: 546-554. (Pubitemid 46192191)
27. Dewhirst MW, Cao Y, Moeller B (2008) Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nat Rev Cancer 8: 425-37. (Pubitemid 351744964)
28. Marusyk A, Polyak K (2010) Tumor heterogeneity: causes and consequences. Biochim Biophys Acta 805: 105-117.
29. Chi JT, Wang Z, Nuyten DS, Rodriguez EH, Schaner ME (2006) Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers. PLoS Med 3: e47.
30. Denko NC, Fontana LA, Hudson KM, Sutphin PD, Raychaudhuri S, et al. (2003) Investigating hypoxic tumor physiology through gene expression patterns. Oncogene 22: 5907-5914. (Pubitemid 37176711)
31. Lal A1, Peters H, St Croix B, Haroon ZA, Dewhirst MW (2001) Transcriptional response to hypoxia in human tumors. J Natl Cancer Inst 93: 1337-1343.
32. Yuan G1, Nanduri J, Khan S, Semenza GL, Prabhakar NR (2008) Induction of HIF-1alpha expression by intermittent hypoxia: involvement of NADPH oxidase, Ca2+ signaling, prolyl hydroxylases, and mTOR. J Cell Physiol 217: 674-85.
33. Bayer C, Vaupel P (2012) Acute versus chronic hypoxia in tumors: Controversial data concerning time frames and biological consequences. Strahlenther Onkol 188: 616-27.
34. Marczyk M, Jaksik R, Polański A, Polańska J (2013) Adaptive Filtering of Microarray Gene Expression Data Based on Gaussian Mixture Decomposition. BMC Bioinformatics 14: 101.
35. Reimer D, Sadr S, Wiedemair A, Stadlmann S, Concin N, et al. (2007) Clinical relevance of E2F family members in ovarian cancer-an evaluation in a training set of 77 patients. Clin Cancer Res 3: 144-151. (Pubitemid 46121863)
36. Wykosky J, Debinski W (2008) The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting. Mol Cancer Res 6: 1795-1806.
37. Busser B, Sancey L, Brambilla E, Coll JL, Hurbin A (2011) The multiple roles of amphiregulin in human cancer. Biochim Biophys Acta 6: 119-131.
38. Jacobs B, De Roock W, Piessevaux H, Van Oirbeek R, Biesmans B, et al. (2009) Amphiregulin and epiregulin mRNA expression in primary tumors predicts outcome in metastatic colorectal cancer treated with cetuximab. J Clin Oncol 27: 5068-5074.
39. Bos PD, Zhang XH, Nadal C, Shu W, Gomis RR, et al. (2009) Genes that mediate breast cancer metastasis to the brain. Nature 459: 1005-1009.
40. Rupec RA1, Baeuerle PA (1995) The genomic response of tumor cells to hypoxia and reoxygenation. Differential activation of transcription factors AP-1 and NF-kappa B. Eur J Biochem 234: 632-40.
41. Chihab R1, Ferry C, Koziel V, Monin P, Daval JL (1998) Sequential activation of activator protein-1-related transcription factors and JNK protein kinases may contribute to apoptotic death induced by transient hypoxia in developing brain neurons. Brain Res Mol Brain Res 63: 105-20.
42. Udayakumar D, Zhang G, Ji Z, Njauw CN, Mroz P, et al. (2011) EphA2 is a critical oncogene in melanoma. Oncogene 30: 4921-4929.
43. Richards H, Williams A, Jones E, Hindley J, Godkin A, et al. (2010) Novel role of regulatory T cells in limiting early neutrophil responses in skin. Immunology 131: 583-592.
44. Vengellur A1, LaPres JJ (2004) The role of hypoxia inducible factor 1alpha in cobalt chloride induced cell death in mouse embryonic fibroblasts. Toxicol Sci 82: 638-46.
45. Greijer AE, van der Groep P, Kemming D, Shvarts A, Semenza GL, et al. (2005) Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1). J Pathol 206: 291-304. (Pubitemid 40903193)
46. Mense SM1, Sengupta A, Zhou M, Lan C, Bentsman G, et al. (2006) Gene expression profiling reveals the profound upregulation of hypoxia-responsive genes in primary human astrocytes. Physiol Genomics 25: 435-49.
47. Benita Y, Kikuchi H, Smith AD, Zhang MQ, Chung DC, et al. (2009) An integrative genomics approach identifies Hypoxia Inducible Factor-1 (HIF-1)-target genes that form the core response to hypoxia. Nucleic Acids Res 37: 4587-4602.
48. Hu X, Wu R, Shehadeh LA, Zhou Q, Jiang C, et al. (2014) Severe hypoxia exerts parallel and cell-specific regulation of gene expression and alternative splicing in human mesenchymal stem cells. BMC Genomics 15: 303.
49. Chen Z, Manley JL (2003) In vivo functional analysis of the histone 3-like TAF9 and a TAF9-related factor, TAF9L. J Biol Chem 278: 35172-35183. (Pubitemid 37102282)
50. Patwari P, Emilsson V, Schadt EE, Chutkow WA, Lee S, et al. (2011) The arrestin domain-containing 3 protein regulates body mass and energy expenditure. Cell Metab 14: 671-683.
51. Law AY, Wong CK (2010) Stanniocalcin-2 is a HIF-1 target gene that promotes cell proliferation in hypoxia. Exp Cell Res 316: 466-476.
52. Yeung HY, Lai KP, Chan HY, Mak NK, Wagner GF, et al. (2005) Hypoxia-inducible factor-1-mediated activation of stanniocalcin-1 in human cancer cells. Endocrinology 146: 4951-4960. (Pubitemid 41446634)
53. Ramirez TA, Jourdan-Le Saux C, Joy A, Zhang J, Dai Q, et al. (2012) Chronic and intermittent hypoxia differentially regulate left ventricular inflammatory and extracellular matrix responses. Hypertens Res 35: 811-818.
54. Murat A, Migliavacca E, Hussain SF, Heimberger AB, Desbaillets I, et al. (2009) Modulation of angiogenic and inflammatory response in glioblastoma by hypoxia. PLoS One 4: e5947.
55. Martin-Rendon E, Hale SJ, Ryan D, Baban D, Forde SP, et al. (2007) Transcriptional profiling of human cord blood CD133+ and cultured bone marrow mesenchymal stem cells in response to hypoxia. Stem Cells 25: 1003-1012. (Pubitemid 46572598)
56. Shirakawa M, Fujiwara Y, Sugita Y, Moon JH, Takiguchi S, et al. (2012) Assessment of stanniocalcin-1 as a prognostic marker in human esophageal squamous cell carcinoma. Oncol Rep 27: 940-946.
57. Tsukahara T, Kawaguchi S, Torigoe T, Kimura S, Murase M, et al. (2008) Prognostic impact and immunogenicity of a novel osteosarcoma antigen, papillomavirus binding factor, in patients with osteosarcoma. Cancer Sci 99: 368-75. (Pubitemid 351228494)
58. Winter SC, Buffa FM, Silva P, Miller C, et al. (2007) Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers. Cancer Res 67: 3441-3449. (Pubitemid 46724885)
59. Toustrup K, Toustrup K, Sørensen BS, Lassen P, Wiuf C, et al. (2012) Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck. Radiother Oncol 102: 122-129.
60. Starmans MH1, Chu KC, Haider S, Nguyen F, Seigneuric R, et al. (2012) The prognostic value of temporal in vitro and in vivo derived hypoxia gene-expression signatures in breast cancer. Radiother Oncol 102: 436-43.